dobutamine has been researched along with celiprolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Matsuzaki, M; Nakamura, Y; Ohkusa, T; Ryoke, T; Tanaka, N | 1 |
2 other study(ies) available for dobutamine and celiprolol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Body Weight; Cardiomyopathies; Celiprolol; Cricetinae; Dobutamine; Dose-Response Relationship, Drug; Heart; Heart Failure; Hemodynamics; Liver; Lung; Mesocricetus; Motor Activity; Myocardium; Organ Size; Random Allocation; Receptors, Adrenergic, beta; Renin; Survival Rate; Ventricular Function, Left | 1998 |